Loading…
Dr. Reddy's Laboratories Limited is projected to rise to $15.91 by 2027, a +17% move from its current price of $13.58. RDY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $13.37 | $13.58 | $13.79 | +0.01% |
| May 30 | $13.29 | $13.58 | $13.88 | +0.02% |
| May 31 | $13.23 | $13.58 | $13.95 | +0.03% |
| Jun 1 | $13.17 | $13.59 | $14.01 | +0.04% |
| Jun 2 | $13.13 | $13.59 | $14.06 | +0.05% |
| Jun 3 | $13.08 | $13.59 | $14.11 | +0.06% |
| Jun 4 | $13.04 | $13.59 | $14.16 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.04 | $13.59 | $14.16 | +0.07% |
| Week 2 | $12.83 | $13.60 | $14.41 | +0.14% |
| Week 3 | $12.68 | $13.61 | $14.61 | +0.21% |
| Week 4 | $12.55 | $13.62 | $14.78 | +0.28% |
| Week 5 | $12.44 | $13.63 | $14.93 | +0.35% |
| Week 6 | $12.34 | $13.64 | $15.07 | +0.42% |
| Week 7 | $12.25 | $13.65 | $15.21 | +0.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company in North America, Europe, India, Russia, and international markets. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others.
The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products, including branded and generic formulations, with therapeutic equivalence to branded products. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, provides contract research services, and manufactures and sells active pharmaceutical ingredients and steroids in response to customer requirements. The Others segment focuses on developing therapies in oncology and inflammation and on research and development of differentiated formulations.
Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
The stock is currently priced at $13.60. RDY has a market capitalization of $11.35B and is ranked 845 by market cap.
A major floor 13.2% below — a decisive break under it would weaken the trend.
The nearest floor, 8.2% below — buyers have tended to step in here.
The nearest ceiling, 3.3% above — a clean break opens room to run.
A major ceiling 9.9% above — clearing it would confirm fresh momentum.
Key RDY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RDY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.62 | Sell | $13.60 | Sell |
| MA 10 | $13.53 | Buy | $13.53 | Buy |
| MA 20 | $13.43 | Buy | $13.47 | Buy |
| MA 50 | $13.45 | Buy | $13.53 | Buy |
| MA 100 | $13.70 | Sell | $13.67 | Sell |
| MA 200 | $13.92 | Sell | $13.86 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.18 | Neutral |
| Stoch RSI (14) | 84.28 | Sell |
| CCI (20) | 44.91 | Neutral |
| Williams %R (14) | -13.18 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 2.65 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 86.82 | Sell |
| TRIX (15) | -0.00 | Sell |
| Awesome (5,34) | 0.24 | Buy |
| Ultimate (7,14,28) | 50.11 | Neutral |
| Momentum (10) | 1.12 | Buy |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 13.67 | Sell |
| ADX (14) | 10.21 | Neutral |
| ATR (14) | 0.19 | Info |
Technically, sentiment is bullish. RSI14 is 50, with the SMA50 at $13.47 and the SMA200 at $13.92. A support level is identified at $12.46, with a resistance at $14.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.46 | $13.58 | $17.57 | 0% | Neutral | |
| $13.00 | $15.91 | $20.39 | +17% | Neutral | |
| $13.64 | $17.01 | $22.36 | +25% | Bullish | |
| $14.85 | $18.78 | $25.21 | +38% | Bullish | |
| $17.93 | $22.99 | $31.40 | +69% | Bullish | |
| $19.64 | $25.48 | $35.35 | +88% | Bullish | |
| $21.72 | $28.50 | $40.09 | +110% | Bullish | |
| $23.79 | $31.54 | $44.93 | +132% | Bullish | |
| $23.02 | $30.82 | $44.44 | +127% | Bullish | |
| $24.80 | $33.51 | $48.85 | +147% | Bullish | |
| $36.34 | $51.21 | $78.20 | +277% | Bullish | |
| $71.71 | $108.39 | $177.36 | +698% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $12.46 | $13.58 | $15.94 | +0.00% |
| June 2026 | $11.86 | $13.84 | $16.45 | +1.88% |
| July 2026 | $11.68 | $13.70 | $16.45 | -0.95% |
| August 2026 | $11.74 | $13.83 | $16.72 | +0.93% |
| September 2026 | $12.04 | $14.24 | $17.32 | +2.95% |
| October 2026 | $12.01 | $14.26 | $17.43 | +0.11% |
| November 2026 | $11.79 | $14.04 | $17.25 | -1.50% |
| December 2026 | $11.92 | $14.24 | $17.57 | +1.40% |
Click any year to see its month-by-month RDY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect RDY to range from $12.46 to $17.57 through 2026. The $13.58 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The RDY price prediction for 2027 points to an average of $15.91 (low $13.00, high $20.39) — a potential gain of +17% on today's $13.58. A consolidation phase looks the most probable path here.
In 2028, RDY is projected to trade between $13.64 and $22.36, averaging $17.01 — a potential gain of +25% from today's $13.58. That is up +7% on the projected 2027 average. Momentum favours further upside here.
Dr. Reddy's Laboratories Limited's 2029 outlook centres on $18.78, within a $14.85 to $25.21 range. That is up +10% on the projected 2028 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, RDY could reach as high as $31.40, with a base case around $22.99 and support toward $17.93 — roughly +69% from $13.58. Momentum favours further upside here.
Expect RDY to range from $19.64 to $35.35 through 2031. The $25.48 average target implies a +88% move from current prices. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The RDY price prediction for 2032 points to an average of $28.50 (low $21.72, high $40.09) — a potential gain of +110% on today's $13.58. Momentum favours further upside here.
In 2033, RDY is projected to trade between $23.79 and $44.93, averaging $31.54 — a potential gain of +132% from today's $13.58. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Dr. Reddy's Laboratories Limited's 2034 outlook centres on $30.82, within a $23.02 to $44.44 range. That is -2% versus the projected 2033 average. That marks a +127% change versus current levels. Momentum favours further upside here.
By 2035, RDY could reach as high as $48.85, with a base case around $33.51 and support toward $24.80 — roughly +147% from $13.58. Buyers look set to stay in control over this stretch.
Expect RDY to range from $36.34 to $78.20 through 2040. The $51.21 average target implies a +277% move from current prices. That is up +53% on the projected 2035 average. Momentum favours further upside here.
The RDY price prediction for 2050 points to an average of $108.39 (low $71.71, high $177.36) — a potential gain of +698% on today's $13.58. Buyers look set to stay in control over this stretch.
Investing $1,000 in RDY today (≈ 73.637703 RDY) could be worth
$7,981.62
+$6,981.62 (+698%) by 2050 · US Dollar
Based on the average projected RDY price of $108.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RDYwould be worth at today's price.
$1,000 invested in RDY on May 27, 2025 (≈ 67.79661 RDY) would be worth
$920.68
-$79.32 (-7.9%) today · 0.92× · US Dollar
Based on a RDY entry price of $14.75 vs. today's $13.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.63 | $996.33 | -0.4% |
| 1 month ago | $13.97 | $972.08 | -2.8% |
| 3 months ago | $14.58 | $931.41 | -6.9% |
| 6 months ago | $14.05 | $966.55 | -3.3% |
| 1 year ago | $14.75 | $920.68 | -7.9% |
| All time (5.0y) ago | $14.56 | $932.95 | -6.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RDY forecast.
Our base-case forecast reaches $27.00 around 2032.
Implied market cap at $27.00: $22.48B
The multi-year forecast shows a bullish trajectory with rising average prices and sizable ROIs. By 2030, the average price is forecast at $22.86 with an ROI of 68.1%. By 2040, the average price is forecast at $50.81 with an ROI of 273.6%.
By 2050, the average price is forecast at $107.73 with an ROI of 692.2%. These projections accompany an ongoing bullish sentiment but remain estimates rather than guarantees, subject to market and regulatory conditions.
Tap a question to reveal the answer.
The forecast shows an average price of $22.86 with a minimum of $17.83 and a maximum of $31.23, and a ROI of 68.1%, with a bullish sentiment.
The forecast indicates a bullish trajectory from 2027 onward, with increasing average prices and ROIs through 2030, 2040, and 2050 (e.g., 2030 ROI 68.1%, 2040 ROI 273.6%, 2050 ROI 692.2%).
Yes. The 2050 max forecast is $176.30, and the 2050 average is $107.73, placing a $100 level within the projected range.
Current price is $13.60 and market cap is $11.35B.
The 30-day range is $12.23 to $15.12.
Dr. Reddy's Laboratories Limited Community Discussion
0Share your Dr. Reddy's Laboratories Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.